Testing effectiveness (Phase 2)Study completedNCT05975099
What this trial is testing
Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme Disease in Participants 18 Through 70 Years of Age
Who this might be right for
Lyme Disease
ModernaTX, Inc. 807